伴IgA沉积的肾小球新月体诊断困境
该研究回顾了2010至2021年间伴肾小球IgA沉积和新月体(排除狼疮肾炎)的天然肾活检285例,其中108例归为IgA肾病、43例归为葡萄球菌或其他感染相关GN/感染相关GN、26例归为ANCA相关GN,101例无法明确分类(X组)。对72例X组随访显示临床工作诊断各异且治疗从支持/抗生素到免疫抑制不等,非免疫抑制亚组肾丢失率较高但未达统计学显著(P=0.11)。
要点
- X组72例随访中临床工作诊断为IgAN者43%、SAGN/IRGN者22%、ANCA-GN者28%、其他7%。
- X组中免疫抑制与非免疫抑制亚组仅C3优势染色和近期感染可能性两项特征有差异(P<0.05)。
核心结论
- 相当数量的伴肾小球新月体和IgA沉积的肾活检中诊断重叠可能无法解决。
- 作者认为可能需要逐例分析、感染持续时使用适当抗生素、对进行性肾功能不全考虑谨慎的免疫抑制治疗以获得最佳肾脏恢复机会。
研究设计与样本
- 回顾性研究,从2010年至2021年的活检档案中识别伴肾小球IgA沉积和新月体(排除狼疮肾炎)的天然肾活检。
- 共识别285例,评估详细临床病理特征,并对部分病例获取1年临床随访。
主要发现
- 285例聚类为IgA肾病(IgAN,n=108)、葡萄球菌或其他感染相关GN/感染相关GN(SAGN/IRGN,n=43)和ANCA相关GN(ANCA-GN,n=26),但101例(X组)无法明确区分。
- X组无法区分的最重要原因是临床病理特征的非典型组合和缺乏活动性感染的明确证据。
- X组72例随访中,临床工作诊断为IgAN者43%、SAGN/IRGN者22%、ANCA-GN者28%、其他7%。
- X组各亚组治疗从支持治疗或抗生素到免疫抑制不等。
- X组中“接受免疫抑制”与“非免疫抑制”比较,仅C3优势染色和近期感染可能性两项特征有差异(均非免疫抑制组更高)(P<0.05)。
临床怎么用
- 作者认为可能需要逐例分析、感染持续时使用适当抗生素、对进行性肾功能不全考虑谨慎的免疫抑制治疗以获得最佳肾脏恢复机会。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Glomerulonephritis (GN) with crescents and IgA deposits in kidney biopsy poses a frequent diagnostic and therapeutic dilemma because of multiple possibilities. METHODS: Native kidney biopsies showing glomerular IgA deposition and crescents (excluding lupus nephritis) were identified from our biopsy archives between 2010 and 2021. Detailed clinicopathologic features were assessed. One-year clinical follow-up on a subset of cases was obtained. RESULTS: A total of 285 cases were identified, and these clustered into IgA nephropathy (IgAN, n = 108), Staphylococcus or other infection-associated GN/infection-related GN (SAGN/IRGN, n = 43), and antineutrophil cytoplasmic antibody-associated GN (ANCA-GN, n = 26) based on a constellation of clinicopathologic features, but 101 cases (group X) could not be definitively differentiated. The reasons have been elucidated, most important being atypical combination of clinicopathologic features and lack of definitive evidence of active infection. Follow-up (on 72/101 cases) revealed that clinicians' working diagnosis was IgAN in 43%, SAGN/IRGN in 22%, ANCA-GN in 28%, and others in 7% of the cases, but treatment approach varied from supportive or antibiotics to immunosuppression in each subgroup. Comparing these cases as "received immunosuppression" versus "non-immunosuppression," only 2 features differed, namely C3-dominant staining, and possibility of recent infection (both higher in the no-immunosuppression group) (P < 0.05). Renal loss was higher in the non-immunosuppression subgroup, but not statistically significant (P = 0.11). CONCLUSION: Diagnostic overlap may remain unresolved in a substantial number of kidney biopsies with glomerular crescents and IgA deposits. A case-by-case approach, appropriate antibiotics if infection is ongoing, and consideration for cautious immunosuppressive treatment for progressive renal dysfunction may be needed for best chance of renal recovery.
引用
- Kitamura M, Almaani S, Challa B, et al. The Diagnostic Conundrum of Glomerular Crescents With IgA Deposits. Kidney Int Rep. 2022. PMID: 36938067. doi:10.1016/j.ekir.2022.12.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。